Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Allscripts Healthcare Solutions

Related MDRX
Allscripts Posts Its Sixth Straight Quarter Of New Order Growth
22 Stocks Which Rallied Four Days, Then Sold Off On Friday

In a report published Friday, Jefferies & Company reiterated its Hold rating on Allscripts Healthcare Solutions (NASDAQ: MDRX), and raised its price target from $10.50 to $13.00.

Jefferies noted, “Dismal 3Q results were attributed to customer hesitation on MDRX's a) corporate future and b) NT product future. The acknowledgment of a deal process puts a floor in the stock. Maybe even drives some upside. Many long-awaited releases go GA this month, but NT impact on bookings is questionable. 2012 guidance was withdrawn. A lower go-forward tax rate and share count offset nearly all of our reduction in 2013 pre-tax income.”

Allscripts Healthcare Solutions closed on Thursday at $12.26.

Latest Ratings for MDRX

Oct 2016UBSInitiates Coverage onBuy
Sep 2016Cowen & Co.DowngradesOutperformMarket Perform
Aug 2016Leerink SwannUpgradesMarket PerformOutperform

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (MDRX)

View Comments and Join the Discussion!